Pharmafile Logo
Pharmafocus logo
Advanced Search

Mylan’s generic of best-selling GSK drug delayed by FDA

March 30, 2017
Sales and Marketing Advair, GSK, Mylan

Mylan’s plan to bring its generic competitor to GSK’s best-selling respiratory drug, Advair, has hit a major snag after it …

News
roche_close

First treatment for form of MS approved by FDA

March 30, 2017
Sales and Marketing Biogen, Genentech, MS, Roche

In big news for sufferers of MS and the company that developed the drug, Roche subsidiary Genetech, the FDA has …

News
novartis_outside_1

Novartis investigational CAR-T therapy gets FDA priority review

March 30, 2017
Sales and Marketing CTL019, FDA, Novartis, leukaemia

Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 (tisagenlecleucel-T) has been awarded has been awarded priority review by …

News
nhs_bands

Women are 77% of NHS workforce but occupy only 41% board positions

March 29, 2017
Medical Communications NHS

A new report, entitled Women on NHS board: 50:50 by 2020, found that women occupied only 41% of board positions …

News
pharmafocus_april_front_cover

The April 2017 edition of Pharmafocus is available to read online now!

March 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

From industry reaction to NICE’s new regulatory guidelines to the rising threat of counterfeit medicine, you can read all the …

News
evatar

Replica reproductive tract could aid drug trials

March 29, 2017
Research and Development Woodruff lab

If most people were asked whether they had heard of a scandal in the pharmaceutical industry, the drug that would …

News
diabetes-777001_960_720

New drug therapy ‘reverses’ diabetes in mice

March 29, 2017
Research and Development diabetes

A team of researchers at the University of California, San Diego (UCSD) have developed a drug therapy which has shown …

News
sanofi_regeneron

Breakthrough eczema drug given FDA approval

March 29, 2017
Research and Development, Sales and Marketing Dupixent, Regeneron, Sanofi

Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …

News
nhs_bands

Cuts to prescriptions aims to save £128 million annually

March 28, 2017
Medical Communications, Research and Development NHS England, prescription

NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …

News
ludwig_hantson_small

Alexion leadership uncertainty ends as ex-Baxalta CEO steps in

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, CEO

Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …

Appointment

Renowned scientist Owen N. Witte joins Kite Pharma Board of Directors

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Kite Pharma has revealed the addition of celebrated bioscientist and researcher Dr Owen N. Witte to its Board of Directors, …

Appointment
mylan

Mylan set to close Meda US manufacturing facility

March 28, 2017
Manufacturing and Production Meda, Mylan

Mylan continues to cut away Meda’s US operations to “reduce redundancy” – the latest sees Mylan closing an Illinois-based facility, …

News
valeant_web

Former Valeant CEO Michael Pearson sues over $30m unpaid shares

March 28, 2017
Manufacturing and Production, Sales and Marketing Michael Pearson, Valeant

Ex-Valeant CEO Michael Pearson is suing his former company over its failure to deliver three million shares he claims he …

News
ema_building_face_web

EMA recommends suspension of 331 drugs over testing concerns

March 28, 2017
Manufacturing and Production, Sales and Marketing Aurobindo, Micro Therapeutic Research Labs, Novartis, Sandoz

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has called for the suspension of 331 drugs due to …

News
computer_and_doctor

45% of healthcare professionals not disclosing payments from industry

March 28, 2017
Manufacturing and Production, Medical Communications ABPI, disclosure, disclosure uk

The research organisation ABPI, alongside RAND Europe, has released a ‘snapshot’ of data, from its Disclosure UK database, from January …

News

Butterworth Laboratories secures additional facility

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Leading UK contract analytical chemistry provider, Butterworth Laboratories Ltd, is delighted to announce it has secured an additional facility in …

News
Press release
blood-75302_960_720

Manufacture of red blood cells possible after research breakthrough

March 27, 2017
Manufacturing and Production, Research and Development Stem cells, University of Bristol

Researchers from the University of Bristol and NHS Blood and Transplant have managed to perfect a technique whereby it is …

News
forte

Bone Therapeutics strengthens leadership with new CMO

March 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bone therapeutics

Bone Therapeutics, a bone cell therapy company focusing on orthopaedics and bone disease, has appointed Miguel Forte to the position …

Appointment
figure-1691868_960_720

Pfizer receive European approval for arthritis drug

March 27, 2017
Sales and Marketing Pfizer, rheumatoid arthritis

Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given …

News
upper-body-944557_960_720

Treatment combating multi-drug resistant TB posts positive results

March 27, 2017
Research and Development, Sales and Marketing Infectex, Sequella, tuberculosis

Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026